1. Home
  2. EXK vs LQDA Comparison

EXK vs LQDA Comparison

Compare EXK & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Endeavour Silver Corporation (Canada)

EXK

Endeavour Silver Corporation (Canada)

HOLD

Current Price

$10.27

Market Cap

3.4B

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$39.15

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXK
LQDA
Founded
1981
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.1B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
EXK
LQDA
Price
$10.27
$39.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$13.94
$41.00
AVG Volume (30 Days)
8.7M
964.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.81
EPS
N/A
N/A
Revenue
N/A
$158,320,000.00
Revenue This Year
$63.94
$278.87
Revenue Next Year
$8.76
$57.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1031.18
52 Week Low
$3.23
$11.85
52 Week High
$15.15
$46.67

Technical Indicators

Market Signals
Indicator
EXK
LQDA
Relative Strength Index (RSI) 54.09 55.54
Support Level $8.33 $31.75
Resistance Level $10.31 $46.67
Average True Range (ATR) 0.54 2.01
MACD 0.18 0.27
Stochastic Oscillator 80.59 62.95

Price Performance

Historical Comparison
EXK
LQDA

About EXK Endeavour Silver Corporation (Canada)

Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: